BREAKOUT STOCK ALERT
$ECOR - electroCore, Inc. - Common Stock
Initial Alert Price: $2.26
Potential Price: $3.3
Potential Gains: 46.02
Stop Loss Limit: $
Re-Entry Trade Alert:
ECOR is currently trading at the bottom of it's long-term trend line providing the opportunity to re-enter into the trade and retest the $3.30 Levels for a potential 40-45% Swing Trade over the next few weeks.
The company announced on Feb. 24th that the completion of patient enrollment in SAVIOR-1, or "Prospective, Randomized, Controlled Study to Evaluate the Effect of Non-Invasive Electrical Vagus Nerve Stimulation on Respiratory Symptoms due to COVID-19."
The company also announced the Australian Government Department of Health approved the company's GammaCore Migraine Therapy Vagus Nerve Electrical Simulator.
From a fundamental long-term outlook, the company is showing 24% EPS YoY and +197% Growth in Net Profit Margin YoY. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
$ECOR - electroCore, Inc. - Common Stock
Initial Alert Price: $2.26
Potential Price: $3.3
Potential Gains: 46.02
Stop Loss Limit: $
Re-Entry Trade Alert:
ECOR is currently trading at the bottom of it's long-term trend line providing the opportunity to re-enter into the trade and retest the $3.30 Levels for a potential 40-45% Swing Trade over the next few weeks.
The company announced on Feb. 24th that the completion of patient enrollment in SAVIOR-1, or "Prospective, Randomized, Controlled Study to Evaluate the Effect of Non-Invasive Electrical Vagus Nerve Stimulation on Respiratory Symptoms due to COVID-19."
The company also announced the Australian Government Department of Health approved the company's GammaCore Migraine Therapy Vagus Nerve Electrical Simulator.
From a fundamental long-term outlook, the company is showing 24% EPS YoY and +197% Growth in Net Profit Margin YoY. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
